CENTRAL NERVOUS SYSTEM INVASION IN EARLY LYME DISEASE
早期疾病中的中枢神经系统侵袭
基本信息
- 批准号:6273873
- 负责人:
- 金额:$ 15.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-04-01 至 1999-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Lyme disease, due to the spirochete Borrelia burgdorferi, is a major
emerging infection in our country. Neurologic involvement has become the
significant morbidity of this infection, but has not been well studied.
Effective public health poll is being hampered by lack off basic
information on clinical and laboratory features and pathogenetic
mechanisms of Lyme disease. The objective of this proposal is to identify
the frequency, clinical correlate and outcome of central nervous system
(CNS) infection in early Lyme disease. This study will focus on 3 adult
case groups (N=100) with newly acquired infection: 1) single lesion
erythema migrans (EM) (N=25); 2) multifocal EM (N=25); 3) neurologic Lyme
disease (N=50). All eligible patient will meet Centers for Disease Control
and Prevention diagnostic criteria for Lyme disease. After an initial
comprehensive evaluation (self report forms to assess clinical symptoms,
psychosocial and psychiatric measures, and health outcome; skin, blood and
cerebrospinal fluid (CSF) studies; cognitive assessment) subjects will
receive standard antibiotic treatment, and then be followed prospectively
for 18 months. Comparison groups will be healthy subjects (N=1 00)
frequency matched to cases on age, education and gender; and subjects with
other neurologic diseases (N=50).
Specific Aim 1: To determine the frequency of CNS invasion in early local
and disseminated Lyme disease (invasion will be defined by positive CSF
culture, Borrelial antigen, Borrelial DNA, or intrathecal Borrelial
antibodies); to document neurologic complaints and health function status
of early infection patients.
Hypothesis: CNS invasion by B. burgdorferi is common during early
infection. Corollary: neurologic complaints are frequent in early Lyme
disease. Corollary: in this population new onset of headache is a clinical
marker of CNS invasion, while CSF IgM reactivity to B.burgdorferi is an
immune marker of CNS invasion.
Specific Aim 2: To examine the outcome of neurologic involvement in,early
Lyme disease.
Hypothesis: Following infection, patients with persistent CSF
abnormalities (defined as CNS invasion markers; Borrelial immune
complexes; or abnormal cell count or protein) will be symptomatic.
Corollary: clearance of CSF is associated with clinical improvement.
Specific Aim 3: To determine the proportion of early Lyme disease patients
who develop late encephalopathy. Question: what proportion of early Lyme
patients will develop persistent neurobehavioral dysfunction in domains of
attention and memory?
This proposal will help characterize the neurologic aspects of early Lyme
disease, will aid in diagnosis and management, and will help guide the
formulation of a rational and cost effective health care program for Lyme
disease.
莱姆病,由于螺旋体伯氏疏螺旋体,是一个主要的
在我国出现感染。神经系统受累已经成为
这种感染的发病率很高,但尚未得到充分研究。
有效的公共卫生民意调查因缺乏基本的
临床和实验室特征以及发病机制的信息
莱姆病的发病机制本建议的目的是确定
中枢神经系统损害发生率、临床相关因素及转归
(CNS)莱姆病早期感染。这项研究将集中在3个成年人
新发感染病例组(N=100):1)单病灶
游走性红斑(EM)(N=25); 2)多灶性EM(N=25); 3)神经系统莱姆病
疾病(N=50)。所有符合条件的患者将符合疾病控制中心
和莱姆病预防诊断标准。经过初步
综合评估(自我报告表以评估临床症状,
心理社会和精神病学措施,以及健康结果;皮肤、血液和
脑脊液(CSF)研究;认知评估)受试者将
接受标准抗生素治疗,然后进行前瞻性随访
18个月比较组为健康受试者(N=1 00)
频率与年龄、教育和性别的病例相匹配;
其他神经系统疾病(N=50)。
具体目标1:确定早期局部CNS侵袭的频率
和播散性莱姆病(侵袭将由阳性CSF定义
培养、疏螺旋体抗原、疏螺旋体DNA或鞘内疏螺旋体
抗体);记录神经系统疾病和健康功能状态
早期感染患者。
假设:B侵入CNS。Burgdorferi在早期很常见。
感染推论:神经系统疾病在早期莱姆病中很常见
疾病推论:在这一人群中,新发头痛是一种临床
中枢神经系统侵袭的标志物,而脑脊液中对伯氏B菌的IgM反应性是一种
CNS侵袭免疫标志物。
具体目标2:检查神经系统受累的结果,
莱姆病
假设:感染后,持续性CSF患者
异常(定义为CNS侵袭标志物;疏螺旋体免疫
复合物;或异常细胞计数或蛋白质)将是有症状的。
推论:CSF的清除与临床改善相关。
具体目标3:确定早期莱姆病患者的比例
患有晚期脑病的人。问题:早期莱姆的比例是多少
患者将在以下领域出现持续性神经行为功能障碍:
注意力和记忆力?
这一建议将有助于表征早期莱姆神经方面
疾病,将有助于诊断和管理,并将有助于指导
为莱姆病制定合理和具有成本效益的医疗保健计划
疾病
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PATRICIA K COYLE其他文献
PATRICIA K COYLE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PATRICIA K COYLE', 18)}}的其他基金
STUDY COMPARING THE COMBINED USE OF AVONEX AND COPAXONE
AVONEX 和 COPAXONE 联合使用的比较研究
- 批准号:
7607880 - 财政年份:2007
- 资助金额:
$ 15.55万 - 项目类别:
BLOOD BRAIN BARRIER PERMEABILITY IN MS LESION DEVELOPMENT
MS 病变发展中的血脑屏障通透性
- 批准号:
7375409 - 财政年份:2005
- 资助金额:
$ 15.55万 - 项目类别:
BLOOD BRAIN BARRIER PERMEABILITY IN MS LESION DEVELOPMENT
MS 病变发展中的血脑屏障通透性
- 批准号:
7203688 - 财政年份:2004
- 资助金额:
$ 15.55万 - 项目类别:
Blood Brain Barrier Permeability In MS Lesion Development
多发性硬化症病变发展中的血脑屏障渗透性
- 批准号:
7044318 - 财政年份:2003
- 资助金额:
$ 15.55万 - 项目类别:
CENTRAL NERVOUS SYSTEM INVASION IN EARLY LYME DISEASE
早期疾病中的中枢神经系统侵袭
- 批准号:
6443419 - 财政年份:2001
- 资助金额:
$ 15.55万 - 项目类别:
CENTRAL NERVOUS SYSTEM INVASION IN EARLY LYME DISEASE
早期疾病中的中枢神经系统侵袭
- 批准号:
6302848 - 财政年份:2000
- 资助金额:
$ 15.55万 - 项目类别:
CENTRAL NERVOUS SYSTEM INVASION IN EARLY LYME DISEASE
早期疾病中的中枢神经系统侵袭
- 批准号:
6346300 - 财政年份:2000
- 资助金额:
$ 15.55万 - 项目类别:
CENTRAL NERVOUS SYSTEM INVASION IN EARLY LYME DISEASE
早期疾病中的中枢神经系统侵袭
- 批准号:
6112542 - 财政年份:1999
- 资助金额:
$ 15.55万 - 项目类别:
NEUROLOGIC ASPECTS OF LYME DISEASE IN NORTH AMERICA
北美莱姆病的神经系统方面
- 批准号:
2037946 - 财政年份:1997
- 资助金额:
$ 15.55万 - 项目类别:
NEUROLOGIC ASPECTS OF LYME DISEASE IN NORTH AMERICA
北美莱姆病的神经系统方面
- 批准号:
6187380 - 财政年份:1997
- 资助金额:
$ 15.55万 - 项目类别:
相似海外基金
Immune Modulation During Acute Lyme Disease Infection as the Result of Aberrant Immunoglobulin Glycosylation
异常免疫球蛋白糖基化导致急性莱姆病感染期间的免疫调节
- 批准号:
10726417 - 财政年份:2023
- 资助金额:
$ 15.55万 - 项目类别:
Defining the host and pathogen determinants of peptidoglycan induced pathophysiology in Lyme disease
定义莱姆病肽聚糖诱导的病理生理学的宿主和病原体决定因素
- 批准号:
10566961 - 财政年份:2023
- 资助金额:
$ 15.55万 - 项目类别:
Auto-antibodies as predictive markers for Post treatment Lyme Disease Syndrome
自身抗体作为治疗后莱姆病综合征的预测标记
- 批准号:
10737996 - 财政年份:2023
- 资助金额:
$ 15.55万 - 项目类别:
Neuroimaging and blood markers in post treatment Lyme disease with persistent neurologic symptoms
具有持续神经系统症状的莱姆病治疗后的神经影像学和血液标记物
- 批准号:
10745421 - 财政年份:2023
- 资助金额:
$ 15.55万 - 项目类别:
ImmunoPET Probes for the Imaging of Lyme Disease
用于莱姆病成像的免疫PET探针
- 批准号:
10802275 - 财政年份:2023
- 资助金额:
$ 15.55万 - 项目类别:
Determinants of Post-Treatment Phenotypes in Lyme Disease
莱姆病治疗后表型的决定因素
- 批准号:
10738012 - 财政年份:2023
- 资助金额:
$ 15.55万 - 项目类别:
Elucidating the contributions of c-di-GMP and PlzA to tick- and mammalian host-adaptation in Lyme disease spirochetes
阐明 c-di-GMP 和 PlzA 对莱姆病螺旋体蜱和哺乳动物宿主适应的贡献
- 批准号:
10739945 - 财政年份:2023
- 资助金额:
$ 15.55万 - 项目类别:
The natural release of unusual peptidoglycan fragments drives persistent Lyme disease symptoms in susceptible hosts
异常肽聚糖片段的自然释放导致易感宿主持续出现莱姆病症状
- 批准号:
10736544 - 财政年份:2023
- 资助金额:
$ 15.55万 - 项目类别:
Unlocking serology’s secrets: harnessing novel immune biomarkers to predict Lyme disease progression and recovery
揭开血清学的秘密:利用新型免疫生物标志物来预测莱姆病的进展和恢复
- 批准号:
10737313 - 财政年份:2023
- 资助金额:
$ 15.55万 - 项目类别:
PlzA, cyclic-di-GMP and the enzootic cycle for Lyme disease
PlzA、环二 GMP 和莱姆病的地方性循环
- 批准号:
10608622 - 财政年份:2022
- 资助金额:
$ 15.55万 - 项目类别:














{{item.name}}会员




